Norris Medicines share news, announcements and annual reports
BSE: 524414Commercial Services & SuppliesSmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹14.62.
30 Oct: open ₹14.61, high ₹15.35, low ₹14.02
- Under BSE's graded surveillance, stage 0, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹14 Cr4,400th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 309
Norris Medicines share news and announcements
394 announcements, routine notices left out, newest first. Page 5 of 8.
Aug 2020
14 Aug · Board meeting
Meeting on 24 Aug 2020: quarterly results
Jul 2020
18 Jul · Shareholding for the Period Ended June 30, 2020
Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click ....6 Jul · Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2020
25 Jun · Intimation To Shareholders To Update Their Email Ids
24 Jun · Board meeting
Meeting on 29 Jun 2020: audited results1 Jun · Disclosure Of Material Impact Of Covid-19
May 2020
25 May · Intimation Under Regulation 30 Of The SEBI [Listing Obligations And Disclosure Requirements] Regulations, 2015 For Resume The Business Operations Of The Company.
13 May · Shareholding for the Period Ended March 31, 2020
Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click ....
Apr 2020
18 Apr · Submission Of Certificate Under Reg. 40(9) For The Period Ended March 31, 2020
17 Apr · Compliance Certificate Pursuant To Regulation 7 (3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2020
16 Apr · Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Feb 2020
Jan 2020
29 Jan · Board meeting
Meeting on 6 Feb 2020: quarterly results21 Jan · Shareholding for the Period Ended December 31, 2019
Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click ....5 Jan · Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 4 4 0
Nov 2019
11 Nov · SEBI (Pro Hibit Ion Of Insider Tradi Ng) Regulations, 2015 [Regulation 7 (2) Rea D With Regulation 6(2) - Continual Disclosure]
Oct 2019
23 Oct · Submission Of Standalone Unaudited Financial For The Quarter And Six Months Ended On 30Th September,2019
17 Oct · Shareholding for the Period Ended September 30, 2019
Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click ....16 Oct · Submission Of Certificate Under Reg. 40(9) For The Period Ended September 30, 2019
16 Oct · Board meeting
Meeting on 23 Oct 2019: quarterly results10 Oct · Compliance Certificate For The Period Of 30Th September, 2019